Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer journalArticle 2019 Moreno, A. C.; Frank, S. J.; Garden, A. S.; Rosenthal, D. I.; Fuller, C. D.; Gunn, G. B.; Reddy, J. P.; Morrison, W. H.; Williamson, T. D.; Holliday, E. B.; Phan, J.; Blanchard, P.
Human metapneumovirus in patients hospitalized with acute respiratory infections: A meta-analysis journalArticle 2016 Lefebvre, A.; Manoha, C.; Bour, J. B.; Abbas, R.; Fournel, I.; Tiv, M.; Pothier, P.; Astruc, K.; Aho-Glele, L. S.
Results of external beam radiotherapy for diffuse choroidal hemangiomas in Sturge-Weber syndrome journalArticle 2018 Randon, M.; Lévy-Gabriel, C.; Abbas, R.; Dendale, R.; Lumbroso, L.; Desjardins, L.; Cassoux, N.
biospear: an R package for biomarker selection in penalized Cox regression journalArticle 2018 Ternes, N.; Rotolo, F.; Michiels, S.
Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival journalArticle 2015 Kapetanakis, N. I.; Uzan, C.; Jimenez-Pailhes, A. S.; Gouy, S.; Bentivegna, E.; Morice, P.; Caron, O.; Gourzones-Dmitriev, C.; Le Teuff, G.; Busson, P.
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort journalArticle 2018 Blanchard, P.; Davis, J. W.; Frank, S. J.; Kim, J.; Pettaway, C. A.; Pugh, T. J.; Pisters, L. L.; Ward, J. F.; Choi, S.; Chapin, B. F.; Hoffman, K.; Navai, N.; Achim, M.; McGuire, S. E.; Matin, S. F.; Nguyen, Q.; Mahmood, U.; Graber, W. J.; Chen, H. C.; Wang, X.; Kuban, D. A.
[A new classification for meibomian gland diseases with in vivo confocal microscopy] journalArticle 2016 Randon, M.; Liang, H.; Abbas, R.; Michee, S.; Denoyer, A.; Baudouin, C.; Labbe, A.
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead journalArticle 2015 Minard-Colin, V.; Brugières, L.; Reiter, A.; Cairo, M. S.; Gross, T. G.; Woessmann, W.; Burkhardt, B.; Sandlund, J. T.; Williams, D.; Pillon, M.; Horibe, K.; Auperin, A.; Le Deley, M. C.; Zimmerman, M.; Perkins, S. L.; Raphael, M.; Lamant, L.; Klapper, W.; Mussolin, L.; Poirel, H. A.; Macintyre, E.; Damm-Welk, C.; Rosolen, A.; Patte, C.
Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data journalArticle 2018 Zardavas, D.; Te Marvelde, L.; Milne, R. L.; Fumagalli, D.; Fountzilas, G.; Kotoula, V.; Razis, E.; Papaxoinis, G.; Joensuu, H.; Moynahan, M. E.; Hennessy, B. T.; Bieche, I.; Saal, L. H.; Stal, O.; Iacopetta, B.; Jensen, J. D.; O''''Toole, S.; Lopez-Knowles, E.; Barbaraeschi, M.; Noguchi, S.; Azim, H. A.; Lerma, E.; Bachelot, T.; Wang, Q.; Perez-Tenorio, G.; Can de Velde, C. J. H.; Rea, D. W.; Sabine, V.; Bartlett, J. M. S.; Sotiriou, C.; Michiels, S.; Loi, S.
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma journalArticle 2018 Grill, J.; Massimino, M.; Bouffet, E.; Azizi, A. A.; McCowage, G.; Canete, A.; Saran, F.; Le Deley, M. C.; Varlet, P.; Morgan, P. S.; Jaspan, T.; Jones, C.; Giangaspero, F.; Smith, H.; Garcia, J.; Elze, M. C.; Rousseau, R. F.; Abrey, L.; Hargrave, D.; Vassal, G.
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer journalArticle 2016 Gouy, S.; Ferron, G.; Glehen, O.; Bayar, A.; Marchal, F.; Pomel, C.; Quenet, F.; Bereder, J. M.; Le Deley, M. C.; Morice, P.
Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer journalArticle 2015 Nascimento, C.; Borget, I.; Al Ghuzlan, A.; Deandreis, D.; Hartl, D.; Lumbroso, J.; Berdelou, A.; Lepoutre-Lussey, C.; Mirghani, H.; Baudin, E.; Schlumberger, M.; Leboulleux, S.
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer journalArticle 2018 Devarakonda, S.; Rotolo, F.; Tsao, M. S.; Lanc, I.; Brambilla, E.; Masood, A.; Olaussen, K. A.; Fulton, R.; Sakashita, S.; McLeer-Florin, A.; Ding, K.; Le Teuff, G.; Shepherd, F. A.; Pignon, J. P.; Graziano, S. L.; Kratzke, R.; Soria, J. C.; Seymour, L.; Govindan, R.; Michiels, S.
Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and Controversies journalArticle 2015 Sze, H.; Blanchard, P.; Ng, W. T.; Pignon, J. P.; Lee, A. W.
Age at start of using tobacco on the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium (INHANCE) journalArticle 2019 Chang, C. P.; Chang, S. C.; Chuang, S. C.; Berthiller, J.; Ferro, G.; Matsuo, K.; Wunsch-Filho, V.; Toporcov, T. N.; de Carvalho, M. B.; La Vecchia, C.; Olshan, A. F.; Zevallos, J. P.; Serraino, D.; Muscat, J.; Sturgis, E. M.; Li, G.; Morgenstern, H.; Levi, F.; Dal Maso, L.; Smith, E.; Kelsey, K.; McClean, M.; Vaughan, T. L.; Lazarus, P.; Ramroth, H.; Chen, C.; Schwartz, S. M.; Winn, D. M.; Bosetti, C.; Edefonti, V.; Garavello, W.; Negri, E.; Hayes, R. B.; Purdue, M. P.; Boccia, S.; Cadoni, G.; Shangina, O.; Koifman, R.; Curado, M. P.; Vilensky, M.; Swiatkowska, B.; Herrero, R.; Franceschi, S.; Benhamou, S.; Fernandez, L.; Menezes, A. M. B.; Daudt, A. W.; Mates, D.; Schantz, S.; Yu, G. P.; Lissowska, J.; Brenner, H.; Fabianova, E.; Rudnai, P.; Brennan, P.; Boffetta, P.; Zhang, Z. F.; Hashibe, M.; Lee, Y. A.
A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort journalArticle 2015 Dartois, L.; Gauthier, E.; Heitzmann, J.; Baglietto, L.; Michiels, S.; Mesrine, S.; Boutron-Ruault, M. C.; Delaloge, S.; Ragusa, S.; Clavel-Chapelon, F.; Fagherazzi, G.
New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues journalArticle 2016 Martelli, N.; van den Brink, H.; Borget, I.
Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement journalArticle 2015 Stewart, L. A.; Clarke, M.; Rovers, M.; Riley, R. D.; Simmonds, M.; Stewart, G.; Tierney, J. F.; Group, Prisma-Ipd Development
Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer journalArticle 2015 Deutsch, E.; Le Péchoux, C.; Faivre, L.; Rivera, S.; Tao, Y.; Pignon, J. P.; Angokai, M.; Bahleda, R.; Deandreis, D.; Angevin, E.; Hennequin, C.; Besse, B.; Levy, A.; Soria, J. C.
Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma journalArticle 2016 Regairaz, M.; Munier, F.; Sartelet, H.; Castaing, M.; Marty, V.; Renauleaud, C.; Doux, C.; Delbe, J.; Courty, J.; Fabre, M.; Ohta, S.; Vielh, P.; Michiels, S.; Valteau-Couanet, D.; Vassal, G.
Postoperative radiotherapy for non-small cell lung cancer journalArticle 2016 Burdett, S.; Rydzewska, L.; Tierney, J.; Fisher, D.; Parmar, M. K.; Arriagada, R.; Pignon, J. P.; Le Pechoux, C.; Group, Port Meta-analysis Trialists
Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry journalArticle 2019 Matejcic, M.; Saunders, E. J.; Dadaev, T.; Brook, M. N.; Wang, K.; Sheng, X.; Olama, A. A. A.; Schumacher, F. R.; Ingles, S. A.; Govindasami, K.; Benlloch, S.; Berndt, S. I.; Albanes, D.; Koutros, S.; Muir, K.; Stevens, V. L.; Gapstur, S. M.; Tangen, C. M.; Batra, J.; Clements, J.; Gronberg, H.; Pashayan, N.; Schleutker, J.; Wolk, A.; West, C.; Mucci, L.; Kraft, P.; Cancel-Tassin, G.; Sorensen, K. D.; Maehle, L.; Grindedal, E. M.; Strom, S. S.; Neal, D. E.; Hamdy, F. C.; Donovan, J. L.; Travis, R. C.; Hamilton, R. J.; Rosenstein, B.; Lu, Y. J.; Giles, G. G.; Kibel, A. S.; Vega, A.; Bensen, J. T.; Kogevinas, M.; Penney, K. L.; Park, J. Y.; Stanford, J. L.; Cybulski, C.; Nordestgaard, B. G.; Brenner, H.; Maier, C.; Kim, J.; Teixeira, M. R.; Neuhausen, S. L.; De Ruyck, K.; Razack, A.; Newcomb, L. F.; Lessel, D.; Kaneva, R.; Usmani, N.; Claessens, F.; Townsend, P. A.; Gago-Dominguez, M.; Roobol, M. J.; Menegaux, F.; Khaw, K. T.; Cannon-Albright, L. A.; Pandha, H.; Thibodeau, S. N.; Schaid,
ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors journalArticle 2018 Guerrero-Zotano, A.; Stricker, T.; Formisano, L.; Hutchinson, K. E.; Stover, D. G.; Lee, K. M.; Schwarz, L. J.; Giltnane, J. M.; Estrada, M. V.; Jansen, V. M.; Servetto, A.; Gavilá, J.; Pérez-Fidalgo, J. A.; Lluch, A.; Llombart-Cussac, A.; Bayar, M. A.; Michiels, S.; Andre, F.; Arnedos, M.; Guillem, V.; Ruiz-Simon, A.; Arteaga, C. L.
Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumor journalArticle 2015 Joskin, J.; de Baere, T.; Auperin, A.; Tselikas, L.; Guiu, B.; Farouil, G.; Boige, V.; Malka, D.; Leboulleux, S.; Ducreux, M.; Baudin, E.; Deschamps, F.
Modalités de surveillance des patients suivis pour un cancer de la prostate avancé : résultats d’une enquête nationale de pratique journalArticle 2016 Rozet, F.; Roupret, M.; Hennequin, C.; Massard, C.; Blanchard, P.; Le moulec, S.
Statistical evaluation of surrogate endpoints with examples from cancer clinical trials journalArticle 2016 Buyse, M.; Molenberghs, G.; Paoletti, X.; Oba, K.; Alonso, A.; Van der Elst, W.; Burzykowski, T.
Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium journalArticle 2017 Bautista, F.; Moreno, L.; Marshall, L.; Pearson, A. D. J.; Geoerger, B.; Paoletti, X.
Underuse of self-controlled designs in pharmacoepidemiology in electronic healthcare databases: a systematic review journalArticle 2016 Gault, N.; Castaneda-Sanabria, J.; Guillo, S.; Foulon, S.; Tubach, F.
[Data sources, the data used, and the modality for collection] journalArticle 2018 Mercier, G.; Costa, N.; Dutot, C.; Riche, V. P.
How to Model Survival In Cost-Effectiveness Analysis? Differences Between Markov and Partitioned Survival Analysis Models journalArticle 2015 Minacori, R.; Bonastre, J.; Lueza, B.; Marguet, S.; Levy, P.
Prevention of serious skeletal-related events by interventional radiology techniques in patients with malignant paraganglioma and pheochromocytoma journalArticle 2018 Gravel, G.; Leboulleux, S.; Tselikas, L.; Fassio, F.; Berraf, M.; Berdelou, A.; Ba, B.; Hescot, S.; Hadoux, J.; Schlumberger, M.; Al Ghuzlan, A.; Nguyen, F.; Faron, M.; de Baere, T.; Baudin, E.; Deschamps, F.
Telomere shortening: a new prognostic factor for cardiovascular disease post-radiation exposure journalArticle 2015 M'Kacher, R.; Girinsky, T.; Colicchio, B.; Ricoul, M.; Dieterlen, A.; Jeandidier, E.; Heidingsfelder, L.; Cuceu, C.; Shim, G.; Frenzel, M.; Lenain, A.; Morat, L.; Bourhis, J.; Hempel, W. M.; Koscielny, S.; Paul, J. F.; Carde, P.; Sabatier, L.
Radiation-Related Alterations of Taste Function in Patients With Head and Neck Cancer: a Systematic Review journalArticle 2018 Deshpande, T. S.; Blanchard, P.; Wang, L.; Foote, R. L.; Zhang, X.; Frank, S. J.
Clinical outcomes after interstitial brachytherapy for early-stage nasal squamous cell carcinoma journalArticle 2017 Bacorro, W.; Escande, A.; Temam, S.; Dumas, I.; Routier, E.; Gensse, M. C.; Blanchard, P.; Janot, F.; Mateus, C.; Tao, Y.; Robert, C.; Deutsch, E.; Haie-Meder, C.; Chargari, C.
Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement journalArticle 2015 Stewart, L. A.; Clarke, M.; Rovers, M.; Riley, R. D.; Simmonds, M.; Stewart, G.; Tierney, J. F.; Group, Prisma-Ipd Development
[Prophylactic nodal radiotherapy in prostate cancer] journalArticle 2019 Bourdais, R.; Achkar, S.; Chauffert-Yvart, L.; Pasquier, D.; Sargos, P.; Blanchard, P.; Latorzeff, I.
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials journalArticle 2015 Coleman, R.; Powles, T.; Paterson, A.; Gnant, M.; Anderson, S.; Diel, I.; Gralow, J.; von Minckwitz, G.; Moebus, V.; Bergh, J.; Pritchard, K. I.; Bliss, J.; Cameron, D.; Evans, V.; Pan, H.; Peto, R.; Bradley, R.; Gray, R.
Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study journalArticle 2018 Marino, P.; Touzani, R.; Perrier, L.; Rouleau, E.; Kossi, D. S.; Zhaomin, Z.; Charrier, N.; Goardon, N.; Preudhomme, C.; Durand-Zaleski, I.; Borget, I.; Baffert, S.
European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancer journalArticle 2016 Marguet, S.; Mazouni, C.; Ramaekers, B. L.; Dunant, A.; Kates, R.; Jacobs, V. R.; Joore, M. A.; Harbeck, N.; Bonastre, J.
Relationship Between Carfilzomib Dose and Efficacy Outcomes in Patients With Relapsed and/or Refractory Multiple Myeloma journalArticle 2015 Squifflet, P.; Michiels, S.; Siegel, D.; Vij, R.; Jagannath, S.; Saad, E. D.; Rajangam, K.; Ro, S. K.; Buyse, M.